Animal to human translational paradigms relevant for approach avoidance conflict decision making

Behaviour Research and Therapy
Namik KirlicRobin L Aupperle

Abstract

Avoidance behavior in clinical anxiety disorders is often a decision made in response to approach-avoidance conflict, resulting in a sacrifice of potential rewards to avoid potential negative affective consequences. Animal research has a long history of relying on paradigms related to approach-avoidance conflict to model anxiety-relevant behavior. This approach includes punishment-based conflict, exploratory, and social interaction tasks. There has been a recent surge of interest in the translation of paradigms from animal to human, in efforts to increase generalization of findings and support the development of more effective mental health treatments. This article briefly reviews animal tests related to approach-avoidance conflict and results from lesion and pharmacologic studies utilizing these tests. We then provide a description of translational human paradigms that have been developed to tap into related constructs, summarizing behavioral and neuroimaging findings. Similarities and differences in findings from analogous animal and human paradigms are discussed. Lastly, we highlight opportunities for future research and paradigm development that will support the clinical utility of this translational work.

References

Jan 1, 1978·British Journal of Pharmacology·S E File, J R Hyde
Oct 1, 1992·Pharmacology, Biochemistry, and Behavior·K L KopchiaR L Commissaris
Jan 1, 1991·Psychopharmacology·E YadinH L Grishkat
Jan 1, 1990·Pharmacology & Therapeutics·R G Lister
Jul 1, 1986·Pharmacology, Biochemistry, and Behavior·M A GeyerV L Masten
Jan 1, 1982·Psychopharmacology·M R Landauer, R L Balster
Jul 1, 1995·Physiology & Behavior·B E WeeG P Dohanich
Feb 1, 1997·Pharmacology, Biochemistry, and Behavior·M G CutlerJ E Jackson
Feb 10, 1998·Journal of Anxiety Disorders·S G HofmannW T Roth
Feb 1, 2000·Trends in Cognitive Sciences·S R LangtonI Bruce
Mar 24, 2000·Cerebral Cortex·A BecharaA R Damasio
Feb 13, 2001·Journal of Affective Disorders·P J LangA Ohman
Mar 13, 2001·Molecular Psychiatry·M Davis, P J Whalen
Sep 15, 2001·Science·J D GreeneJ D Cohen
Jun 5, 2002·Physiology & Behavior·Wen-Sung Lai, Robert E Johnston
Jul 24, 2002·Brain : a Journal of Neurology·S BerthozR J Dolan
Aug 1, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kirsten G KjelstrupMay-Britt Moser
Aug 31, 2002·Psychopharmacology·Franco BorsiniDonatella Marazziti
Nov 7, 2002·Physiology & Behavior·J Haller, N Bakos
Dec 5, 2002·Journal of Anxiety Disorders·Kaye HorleyEvian Gordon
Feb 26, 2003·European Journal of Pharmacology·Laetitia Prut, Catherine Belzung
Feb 26, 2003·European Journal of Pharmacology·Sandra E File, Pallab Seth
Feb 26, 2003·European Journal of Pharmacology·Michel Bourin, Martine Hascoët
Feb 26, 2003·European Journal of Pharmacology·Mark J Millan, Mauricette Brocco
Mar 13, 2003·Cerebral Cortex·Simon Killcross, Etienne Coutureau
Mar 19, 2003·Behavioural Brain Research·Robert M J DeaconJ Nicholas P Rawlins
Mar 19, 2003·Behavioural Brain Research·D M BannermanJ N P Rawlins
Jun 26, 2003·Neuroreport·Hauke R HeekerenArno Villringer
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Oct 11, 2003·Science·Naomi I EisenbergerKipling D Williams
Nov 20, 2003·Nature Neuroscience·Jennifer A RichesonJ Nicole Shelton
Feb 26, 2004·Behavioral Neuroscience·S B McHughD M Bannerman
Jul 1, 2004·Neuroscience and Biobehavioral Reviews·D M BannermanJ Feldon
Jul 1, 2004·Neuroscience and Biobehavioral Reviews·Neil McNaughton, Philip J Corr
Oct 12, 2004·Neuron·Joshua D GreeneJonathan D Cohen

❮ Previous
Next ❯

Citations

Jul 10, 2019·Psychopharmacology·Sara OberrauchChristopher R Pryce
Oct 1, 2020·Cellular and Molecular Life Sciences : CMLS·Anne-Kathrin GellnerRené Hurlemann
Apr 27, 2019·Journal of Clinical and Experimental Neuropsychology·Jony SheyninAhmed A Moustafa
Dec 25, 2019·Proceedings of the National Academy of Sciences of the United States of America·Angela C Roberts, Hannah F Clarke
May 13, 2020·Nature Human Behaviour·Dominik R BachRaymond J Dolan
Apr 27, 2018·Molecular Psychiatry·Kimberly H LeBlancAlexxai V Kravitz
Aug 18, 2018·Translational Psychiatry·Dominik R BachAntonia Bantel
May 22, 2019·Nature Human Behaviour·Christoph W Korn, Dominik R Bach
Dec 29, 2020·Journal of the Experimental Analysis of Behavior·Michael W SchlundErin B Tone
Jan 5, 2021·Frontiers in Neuroscience·Kathleen G Bryant, Jacqueline M Barker
Jan 11, 2021·Behaviour Research and Therapy·Anneloes M HulsmanFloris Klumpers
Dec 1, 2020·Frontiers in Behavioral Neuroscience·Jianfeng LiuDevin Mueller
Feb 21, 2021·Neuroscience and Biobehavioral Reviews·Gavan P McNally
Mar 13, 2021·Current Behavioral Neuroscience Reports·Alexandra C PikeOliver J Robinson
Nov 6, 2018·Behaviour Research and Therapy·Angelos-Miltiadis KrypotosIris M Engelhard
Jan 7, 2019·Neuroscience and Biobehavioral Reviews·Fiona PatrickAdam M Perkins
Jun 10, 2021·Scientific Reports·Felix H KlaassenKarin Roelofs
Jul 28, 2021·Neuroscience and Biobehavioral Reviews·Samuel E Cooper, Joseph E Dunsmoor
Aug 18, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Margaux M KenwoodHelen Barbas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.